Gland Pharma Limited announced that at its board Meeting held on March 10, 2022 approved appointment of Mr. Yao Fang as an Additional Director, categorized as Non-Independent and Non-Executive Director, with effect from March 10, 2022 as a Director liable to retire by rotation and resignation of Mr. Li Dongming with effect from the conclusion of Board Meeting on March 10, 2022.